ProQR Therapeutics N.V. financial data

Symbol
PRQR on Nasdaq
Industry
Pharmaceutical Preparations
Location
Zernikedreef 9, Leiden, Netherlands
Fiscal year end
December 31
Former names
ProQR Therapeutics B.V. (to 10/3/2014)
Latest financial report
6-K - Q3 2024 - Nov 7, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 81.4M shares +0.67%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 33.5M EUR +19.1%
General And Administrative Expense 14.5M EUR +0.28%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 107M EUR -24.8%
Liabilities 81.9M EUR -14.4%